Applied BioCode Corporation (6598.TW)

TWD 20.35

(-0.97%)

Total Debt Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual total debt in 2023 was 34.43 Million TWD , down -29.89% from previous year.
Applied BioCode Corporation's latest quarterly total debt in 2024 Q2 was 27.98 Million TWD , down -11.74% from previous quarter.
Applied BioCode Corporation reported annual total debt of 49.11 Million TWD in 2022, down -16.42% from previous year.
Applied BioCode Corporation reported annual total debt of 58.75 Million TWD in 2021, down -4.35% from previous year.
Applied BioCode Corporation reported quarterly total debt of 31.7 Million TWD for 2024 Q1, down -7.91% from previous quarter.
Applied BioCode Corporation reported quarterly total debt of 34.43 Million TWD for 2023 Q4, down -14.41% from previous quarter.

Annual Total Debt Chart of Applied BioCode Corporation (2023 - 2012)

Historical Annual Total Debt of Applied BioCode Corporation (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	34.43 Million TWD	-29.89%
2022	49.11 Million TWD	-16.42%
2021	58.75 Million TWD	-4.35%
2020	61.42 Million TWD	-54.4%
2019	134.69 Million TWD	1484.3%
2018	8.5 Million TWD	0.0%
2017	- TWD	0.0%
2016	- TWD	0.0%
2015	- TWD	0.0%
2014	- TWD	0.0%
2013	- TWD	0.0%
2012	- TWD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	27.98 Million TWD	-11.74%
2024 Q1	31.7 Million TWD	-7.91%
2023 Q4	34.43 Million TWD	-14.41%
2023 FY	34.43 Million TWD	-29.89%
2023 Q2	42.04 Million TWD	-6.53%
2023 Q3	40.22 Million TWD	-4.33%
2023 Q1	44.98 Million TWD	-8.4%
2022 Q1	57.01 Million TWD	-2.96%
2022 Q2	55.34 Million TWD	-2.94%
2022 Q4	49.11 Million TWD	-10.38%
2022 Q3	54.8 Million TWD	-0.97%
2022 FY	49.11 Million TWD	-16.42%
2021 FY	58.75 Million TWD	-4.35%
2021 Q3	57.18 Million TWD	5.83%
2021 Q4	58.75 Million TWD	2.75%
2021 Q1	58.4 Million TWD	-4.92%
2021 Q2	54.03 Million TWD	-7.48%
2020 Q1	134.95 Million TWD	0.19%
2020 Q2	85.7 Million TWD	-36.5%
2020 Q3	76.6 Million TWD	-10.62%
2020 Q4	61.42 Million TWD	-19.81%
2020 FY	61.42 Million TWD	-54.4%
2019 Q1	- TWD	-100.0%
2019 FY	134.69 Million TWD	1484.3%
2019 Q3	260.93 Million TWD	29.16%
2019 Q2	202.02 Million TWD	0.0%
2019 Q4	134.69 Million TWD	-48.38%
2018 Q2	- TWD	0.0%
2018 FY	8.5 Million TWD	0.0%
2018 Q4	8.5 Million TWD	0.0%
2018 Q1	- TWD	0.0%
2017 FY	- TWD	0.0%
2017 Q2	- TWD	0.0%
2017 Q1	- TWD	0.0%
2017 Q3	- TWD	0.0%
2017 Q4	- TWD	0.0%
2016 Q2	- TWD	0.0%
2016 Q4	- TWD	0.0%
2016 FY	- TWD	0.0%
2015 FY	- TWD	0.0%
2015 Q4	- TWD	0.0%
2014 FY	- TWD	0.0%
2013 FY	- TWD	0.0%
2012 FY	- TWD	0.0%

Peer Total Debt Comparison of Applied BioCode Corporation

Name	Total Debt	Total Debt Difference
Excelsior Medical Co., Ltd.	1.44 Billion TWD	97.615%
Apex Medical Corp.	364.55 Million TWD	90.555%
OK Biotech Co., Ltd.	332.97 Million TWD	89.66%